Clinical Trial

Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease

Study acronym: PROFILING
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to define the molecular profile of selected solid tumors. From each participants will be collected biological materials for molecular analysis, including saliva, blood and vital tumor tissue derived form surgical or biopsy procedures. Whereas possible, vital tumor specimens will be inoculated and propagated in immunocompromised NOD/SCID mice to study the genetic correlations between genetic status and response to target drugs.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2017-11-17; most recent amendment 2026-03-17.
Status change: Recruiting → Active, Not Recruiting 2026-03-17
Trial Details
NCT Number NCT03347318
Lead Sponsor Fondazione del Piemonte per l'Oncologia
Conditions Solid Tumors
Enrollment 2,500 participants
Start Date 2011-03-30
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-19